School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Population Health Sciences Division, Royal College of Surgeons in Ireland, Dublin, Ireland; Data Science Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.
Res Social Adm Pharm. 2022 Mar;18(3):2392-2402. doi: 10.1016/j.sapharm.2021.04.011. Epub 2021 Apr 17.
Older adults with cancer often require multiple medications (polypharmacy) comprising cancer-specific treatments, supportive care medications (e.g. analgesics), and medications for pre-existing health conditions. Increasing numbers of medications may increase risks of potentially inappropriate prescribing and non-adherence.
To provide an overview of evaluations of interventions aimed at optimising medication prescribing and/or adherence in older adults with cancer.
A systematic scoping review was undertaken. Four databases (PubMed, EMBASE, CINAHL, PsycINFO) were searched using relevant search terms (e.g. cancer, older adults). Eligible studies evaluated interventions seeking to improve medication prescribing and/or adherence in older adults (≥65 years) with cancer using a comparative evaluation. All outcomes for studies that met inclusion criteria were included in the review. Extracted data were collated using tables and accompanying narrative descriptive summaries. The review was reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines.
Nine studies met inclusion criteria comprising five randomised controlled trials (RCTs) and four before-and-after study designs. Studies were primarily conducted in oncology clinics, ranging from single study sites to 109 oncology clinics. Sample sizes ranged between 33 and 4844 patients. Interventions most commonly involved patient education (n = 6) delivered by pharmacists or nurses. Three studies reported on prescribing-related outcomes and seven studies reported on adherence-related outcomes, using different terminology and assessment methods. Prescribing-related outcomes focused on medication appropriateness (using Beers criteria) and drug-related problems including drug interactions. Adherence-related outcomes included assessments of self-reported medication adherence and calculation of patients' medication possession ratio.
This scoping review highlights a lack of robust evaluations of interventions aimed at optimising medication prescribing and adherence in older adults with cancer. Future research should improve rigour during intervention development, evaluation and reporting in order to generate findings that could inform future practice.
患有癌症的老年人通常需要服用多种药物(包括癌症特异性治疗药物、支持性护理药物[如镇痛药]以及治疗原有健康状况的药物)。服用的药物数量增加可能会增加潜在不适当处方和不遵医嘱的风险。
对旨在优化癌症老年患者药物处方和/或用药依从性的干预措施进行评估。
进行了系统的范围界定审查。使用相关检索词(例如癌症、老年人)在四个数据库(PubMed、EMBASE、CINAHL、PsycINFO)中进行检索。符合条件的研究评估了旨在通过比较评估提高癌症老年患者(≥65 岁)药物处方和/或用药依从性的干预措施。纳入标准为研究纳入了旨在提高癌症老年患者(≥65 岁)药物处方和/或用药依从性的干预措施,并进行了比较评估。所有符合纳入标准的研究的研究结果均纳入综述。提取的数据使用表格和伴随的叙述性描述性摘要进行汇总。综述报告采用系统评价和荟萃分析扩展的首选报告项目(PRISMA-ScR)指南。
符合纳入标准的研究有 9 项,包括 5 项随机对照试验(RCT)和 4 项前后对照研究设计。研究主要在肿瘤诊所进行,从单一研究地点到 109 个肿瘤诊所不等。样本量范围从 33 例到 4844 例患者。干预措施最常涉及由药剂师或护士提供的患者教育(n=6)。有 3 项研究报告了与处方相关的结果,7 项研究报告了与用药依从性相关的结果,这些研究使用了不同的术语和评估方法。与处方相关的结果侧重于药物的适当性(使用 Beers 标准)和药物相关问题,包括药物相互作用。与用药依从性相关的结果包括评估患者自我报告的用药依从性和计算患者的用药持续时间。
本范围界定综述强调了缺乏对旨在优化癌症老年患者药物处方和用药依从性的干预措施的严格评估。未来的研究应在干预措施的开发、评估和报告过程中提高严谨性,以便生成能够为未来实践提供信息的研究结果。